» Articles » PMID: 27334059

Influence of Periostin-positive Cell-specific Klf5 Deletion on Aortic Thickening in DOCA-salt Hypertensive Mice

Overview
Journal Hypertens Res
Date 2016 Jun 24
PMID 27334059
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic hypertension causes vascular remodeling that is associated with an increase in periostin- (postn) positive cells, including fibroblasts and smooth muscle cells. Krüppel-like factor (KLF) 5, a transcription factor, is also observed in vascular remodeling; however, it is unknown what role KLF5 plays in postn-positive cells during vascular remodeling induced by deoxycorticosterone-acetate (DOCA) salt. We used postn-positive cell-specific Klf5-deficient mice (Klf5KO: Klf5; Postn) and wild-type mice (WT: Klf5; Postn). We implanted a DOCA pellet and provided drinking water containing 0.9% NaCl for 8 weeks. The DOCA-salt treatment induced hypertension in both genotypes, as observed by increases in systolic blood pressure. In WT animals, DOCA-salt treatment increased the aortic medial area compared with the non-treated controls. Similarly, Tgfb1 was overexpressed in the aortas of the DOCA-salt treated WT mice compared with the controls. Immunofluorescence staining revealed that fibroblast-specific protein 1 (FSP1)-α smooth muscle actin (αSMA) myofibroblasts exist in the medial area of the WT aortas after DOCA-salt intervention. Importantly, these changes were not observed in the Klf5KO animals. In conclusion, the results of this study suggest that the presence of KLF5 in postn-positive cells contributes to the pathogenesis of aortic thickening induced by DOCA-salt hypertension.

Citing Articles

Genetic variants and mRNA expression levels of and with hypertension: A combination of case-control study and cohort study.

Han X, Li W, Chen C, Liu J, Sun J, Wang F J Biomed Res. 2024; 39(1):103-113.

PMID: 39187911 PMC: 11873589. DOI: 10.7555/JBR.38.20240208.


Molecular mechanisms and potential therapeutic targets in the pathogenesis of hypertension in visceral adipose tissue induced by a high-fat diet.

Su Z, Sun J, Gao M, Sun W, Kong X Front Cardiovasc Med. 2024; 11:1380906.

PMID: 38689862 PMC: 11058983. DOI: 10.3389/fcvm.2024.1380906.


Cardiac and perivascular myofibroblasts, matrifibrocytes, and immune fibrocytes in hypertension; commonalities and differences with other cardiovascular diseases.

Torimoto K, Elliott K, Nakayama Y, Yanagisawa H, Eguchi S Cardiovasc Res. 2024; 120(6):567-580.

PMID: 38395029 PMC: 11485269. DOI: 10.1093/cvr/cvae044.


Participation of Krüppel-like Factors in Atherogenesis.

Kotlyarov S, Kotlyarova A Metabolites. 2023; 13(3).

PMID: 36984888 PMC: 10052737. DOI: 10.3390/metabo13030448.


Serum Periostin as a Potential Biomarker in Pediatric Patients with Primary Hypertension.

Szyszka M, Skrzypczyk P, Stelmaszczyk-Emmel A, Panczyk-Tomaszewska M J Clin Med. 2021; 10(10).

PMID: 34063373 PMC: 8156565. DOI: 10.3390/jcm10102138.


References
1.
Shindo T, Manabe I, Fukushima Y, Tobe K, Aizawa K, Miyamoto S . Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med. 2002; 8(8):856-63. DOI: 10.1038/nm738. View

2.
Mittal B, Singh A . Hypertension in the developing world: challenges and opportunities. Am J Kidney Dis. 2009; 55(3):590-8. DOI: 10.1053/j.ajkd.2009.06.044. View

3.
Tomasek J, Gabbiani G, Hinz B, Chaponnier C, Brown R . Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002; 3(5):349-63. DOI: 10.1038/nrm809. View

4.
Sogawa K, Imataka H, Yamasaki Y, Kusume H, Abe H, Fujii-Kuriyama Y . cDNA cloning and transcriptional properties of a novel GC box-binding protein, BTEB2. Nucleic Acids Res. 1993; 21(7):1527-32. PMC: 309358. DOI: 10.1093/nar/21.7.1527. View

5.
Schiffrin E . Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension. 1995; 25(6):1135-43. DOI: 10.1161/01.hyp.25.6.1135. View